Related references
Note: Only part of the references are listed.Influence of Fructooligosaccharide on Pharmacokinetics of Isoflavones in Postmenopausal Women
Supanimit Teekachunhatean et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Absorption and Plasma Disposition of Genistin Differ from Those of Genistein in Healthy Women
Bo Yuan et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial
Yuko Tousen et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women
Bruce P. Burnett et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2011)
The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women
D. Lee Alekel et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial
Anne M. Kenny et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial
William W. Wong et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo
Maria L. H. Vlaming et al.
CLINICAL CANCER RESEARCH (2009)
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women
M. Atteritano et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
Joseph M. Custodio et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
A. Bitto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The key importance of soy isoflavone bioavailability to understanding health benefits
Theresa Larkin et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2008)
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration
Herbert Marini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Breast Safety and Efficacy of Genistein Aglycone for Postmenopausal Bone Loss: A Follow-Up Study
Herbert Marini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Calciotropic and magnesiotropic TRP channels
Joost G. J. Hoenderop et al.
PHYSIOLOGY (2008)
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial
Herbert Marini et al.
ANNALS OF INTERNAL MEDICINE (2007)
Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract
Martin J. Ronis et al.
JOURNAL OF MEDICINAL FOOD (2006)
Estimated Asian adult soy protein and isoflavone intakes
Mark Messina et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women
XL Zhang et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Involvement of P-glcoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin
Y Wang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Prolonged intake of dietary fermented isoflavone-rich soybean reinforced with zinc affects circulating bone biochemical markers in aged individuals
M Yamaguchi et al.
JOURNAL OF HEALTH SCIENCE (2005)
Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model
J Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption
B Steffansen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance
Y Imai et al.
CANCER RESEARCH (2004)
Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones
M Hu et al.
DRUG METABOLISM AND DISPOSITION (2003)
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study
N Morabito et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Glycemic and insulinemic responses of nondiabetic healthy adult subjects to an experimental acid-induced viscosity complex incorporated into a glucose beverage
BW Wolf et al.
NUTRITION (2002)
Quantitative analysis of, the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection
BF Thomas et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2001)
Phytoestrogen consumption and breast cancer risk in a multiethnic population - The Bay Area Breast Cancer Study
PL Horn-Ross et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
The multispecific organic anion transporter (OAT) family
T Sekine et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2000)
Share Paper
